Health biz sector ripe for action

Reuters: U.S. Healthcare Sector Ripe For More Deals In 2011
The U.S. healthcare industry is poised for a robust year of dealmaking in 2011 as a wider variety of players from scientific tool makers to hospital companies looks for new growth. A quick succession of deals in recent weeks points to the increasing appetite for acquisitions among a broad array of companies. Few expect a return to price-tags like the $67 billion Pfizer Inc paid for Wyeth or the $41 billion Merck & Co spent on Schering-Plough in 2009, but it does mean many more industry names will be targeted in 2011 (Hall and Sherman, 12/22).